comparemela.com

Latest Breaking News On - கெவின் ஸ்சுழ்மான் - Page 4 : comparemela.com

Why vaccine incentives may not be as effective as states hope

ABC News Turn on desktop notifications for breaking stories about interest? OffOn Experts say a key strategy must accompany the perks. • 9 min read By the Numbers: Vaccine incentives A look at some of the giveaways around the country being offered to encourage more COVID-19 vaccinations. SOPA Images/LightRocket via Getty Images, FILE With vaccination numbers declining across the country, leaders in various states are scrambling to put a stick and carrot in front of the millions of residents who have yet to get the shots. From free beers and baseball tickets to a raffle for a car and even cash, governors and city leaders are attempting to encourage those on the fence to roll up their sleeves. But so far, states have not seen upticks in their vaccine administrations, according to data from the Centers for Disease Control and Prevention.

Some Evangelical Christians Have Forgotten Their Moral Duty

Some Evangelical Christians Have Forgotten Their Moral Duty by Dick Polman, April 14, 2021 I don t want to malign anyone s religious faith. I really don t. But it s a tad disturbing that 45 percent of the nation s 41 million white evangelical Christians are vowing not to get vaccinated. As one Texas nutritionist told the press the other day, It would be God s will if I am here or if I am not here. Has this woman not learned that the virus is contagious? And that we ll never reach herd immunity (thwarting the virus due to a dearth of fresh hosts) unless roughly 85 percent of the population is vaccinated? How nice of her to entrust the health of those around her to God s will, without their having a say in the matter.

Convalescent Plasma For COVID-19 Turns Out To Be A Bust : Shots

Embed iframe src https://www.npr.org/player/embed/975365309/975545537 width 100% height 290 frameborder 0 scrolling no title NPR embedded audio player RACHEL MARTIN, HOST: More than half-a-million Americans have gotten an experimental treatment for COVID-19. It s called convalescent plasma. But a year into the pandemic, it is not clear who, if anyone, actually benefits from it. And that highlights the challenges scientists have faced in studying COVID drugs. NPR science correspondent Richard Harris reports. RICHARD HARRIS, BYLINE: On paper, treatment with convalescent plasma makes good sense. The idea is to take blood plasma from people who have recovered from COVID-19 and infuse it into people currently infected. The antibodies in that plasma, in theory, would help fight the virus. So based on that idea, Dr. Nicole Bouvier at the Icahn School of Medicine at Mount Sinai Hospital in New York decided to give it a try last March.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.